The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study

CompletedOBSERVATIONAL
Enrollment

565

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Autism Spectrum Disorder
Trial Locations (5)

27708

Duke, Durham

90027

Children's Hospital Los Angeles, Los Angeles

98105

Unviersity of Washington, Seattle

06519

Yale Child Study Center, New Haven

02445

Boston Children's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

collaborator

Duke University

OTHER

collaborator

Children's Hospital Los Angeles

OTHER

collaborator

University of Washington

OTHER

collaborator

Food and Drug Administration (FDA)

FED

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT05294705 - The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study | Biotech Hunter | Biotech Hunter